P481 Profile of elderly patients in which biological drugs are used for the treatment of inflammatory bowel disease

Autor: C J Suarez Ferrer, F Mesonero, B Caballol, M P Ballester, I Baston Rey, A Castaño Garcia, J Miranda Bautista, R Saiz Chumillas, J M Benitez, L Sanchez Delgado, A Lopez-Garcia, C Rubin de Celio, I Alonso Abreu, L Melcarne, R Plaza Santos, M Marques Cami, A Caballero Mateos, C Gomez Diez, M Calafat, H Alonso Galan, P Vega Vilaamil, B Castro Sensosian, A Guerro Moya, C Y Rodriguez Diaz, K Spicakova, N Manceñido Marcos, G Molina, L De Castro, A Rodriguez Angulo, L Cuevas del Campo, M C Rodriguez Grau, F Ramirez, B Gomez Pastrana, I Gonzalez Partida, B Botella Mateu, E Peña Gonzalez, E Iyo, A Elosua Gonzalez, M Mañosa Ciria, M Barreiro-De Acosta

Publikováno v: Journal of Crohn's and Colitis. 16:i449-i450

Background The use of biological drugs for the treatment of IBD in elderly patients is becoming more frequent in our environment. However, given the greater risk of these patients to develop related adverse effects, the profile of the patients in who

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f2c8d1dc68c1aacac7020e1b8842113f
https://doi.org/10.1093/ecco-jcc/jjab232.608

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU

Autor: L Ramos, Jordina Llaó, E Sesé, M Durà, M. Chaparro, Montserrat Aceituno, P Gilabert, Paola Varela, M F García-Sepulcre, G Suris, Ignacio Marín-Jiménez, L Olivan, Yago González-Lama, J Ortiz de Zárate, José María Huguet, E. Iglesias, Laura Jiménez, I Rodríguez-Lago, E Hinojosa, Fernando Muñoz, Alejandro Hernández-Camba, R Plaza-Santos, F Ramírez Esteso, Cristina Alba, S Estrecha, A Brotons, M Piqueras, Y. Zabana Abdo, José Luis Cabriada, N Rull, A. Lopez-San Roman, M Sierra, E. Domènech, A Fuentes Coronel, Fernando Gomollón, M Esteve, Daniel Carpio, S. Meijilde, A Gutiérrez, Daniel Ginard

Publikováno v: Journal of Crohn's & Colitis
JOURNAL OF CROHNS & COLITIS
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-FISABIO. Repositorio Institucional de Producción Científica

Background The exhaustive registry of COVID-19 cases in patients with IBD is a unique opportunity to learn how to deal with this infection, especially in reference to the management of immunosuppressive treatment, isolation measures or if the disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ae63233e7f57be2b556e004830f5de
http://europepmc.org/articles/PMC8194955

PROXIMAL ADENOMAS AND COLORECTAL CANCER: TWO SHADOWS IN THE EFFECTIVENESS OF COLONOSCOPIC SURVEILLANCE

Autor: M Aldeguer Martínez, F Garrido Gallego, J Barrio Antoranz, L. Adán Merino, C. Zaera de la Fuente, R. Plaza Santos, F Valentín Gomez

Publikováno v: ESGE Days 2018 accepted abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7a926cc7bbe2f0a5b3adc7bd5eddfead
https://doi.org/10.1055/s-0038-1637377

Acute spontaneous tumor lysis syndrome in a patient with Crohn's disease taking immunosuppressants

Autor: C, Froilán Torres, P, Castro Carbajo, R, Pajares Villarroya, R, Plaza Santos, S, Gómez Senent, M D, Martín Arranz, L, Adán Merino, E, Martín Arranz, N, Manceñido Marcos, R, Peces, D, Benito López

Publikováno v: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 101(4)

Acute tumour lysis syndrome (TLS) is a catastrophic complication of the treatment of certain neoplastic disorders. It most commonly occurs in association with hematologic malignancies and appears a few hours to a few days after initiation of specific

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::23e4c669fa89002bb507247f112e68da
https://pubmed.ncbi.nlm.nih.gov/19492906